S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:BSGM

BioSig Technologies (BSGM) Stock Price, News & Analysis

$0.66
-0.07 (-9.45%)
(As of 05:41 PM ET)
Today's Range
$0.65
$0.77
50-Day Range
$0.32
$2.94
52-Week Range
$0.26
$16.50
Volume
268,835 shs
Average Volume
351,138 shs
Market Capitalization
$5.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BSGM stock logo

About BioSig Technologies Stock (NASDAQ:BSGM)

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BSGM Stock Price History

BSGM Stock News Headlines

Biosig Technologies Inc (BSGM)
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
BioSig Announces Reduction of its Workforce
BioSig Announces Reduction of its Workforce
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
BioSig Technologies Inc BSGM
See More Headlines
Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/31/2022
Today
3/28/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:BSGM
Fax
N/A
Employees
47
Year Founded
N/A

Profitability

Net Income
$-27,050,000.00
Pretax Margin
-20,963.12%

Debt

Sales & Book Value

Annual Sales
$290,000.00
Book Value
$0.05 per share

Miscellaneous

Free Float
8,147,000
Market Cap
$5.93 million
Optionable
Optionable
Beta
1.22
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

BSGM Stock Analysis - Frequently Asked Questions

Should I buy or sell BioSig Technologies stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSGM shares.
View BSGM analyst ratings
or view top-rated stocks.

How have BSGM shares performed in 2024?

BioSig Technologies' stock was trading at $4.75 on January 1st, 2024. Since then, BSGM shares have decreased by 86.1% and is now trading at $0.6610.
View the best growth stocks for 2024 here
.

Are investors shorting BioSig Technologies?

BioSig Technologies saw a decline in short interest in March. As of March 15th, there was short interest totaling 669,600 shares, a decline of 25.2% from the February 29th total of 895,000 shares. Based on an average daily trading volume, of 323,300 shares, the short-interest ratio is currently 2.1 days. Currently, 8.7% of the company's shares are short sold.
View BioSig Technologies' Short Interest
.

When is BioSig Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our BSGM earnings forecast
.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) released its earnings results on Thursday, March, 31st. The company reported ($2.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.20) by $0.20.

When did BioSig Technologies' stock split?

Shares of BioSig Technologies reverse split before market open on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Armistice Capital LLC (62.36%), Citadel Advisors LLC (0.86%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy.
View institutional ownership trends
.

How do I buy shares of BioSig Technologies?

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BSGM) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners